Dxome Co., Ltd.

category

  • - CLINICAL & LABORATORY(IVD)

Company Instruction

Dxome Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products, with a primary focus on Next Generation Sequencing (NGS)-based solutions for cancer and infectious diseases. We have pioneered proprietary innovations in both reagent chemistry and bioinformatics, enhancing the robustness and accuracy of our NGS-based molecular assays. Our product portfolio is designed to support treatment selection, monitoring, and early detection, empowering clinicians with precise, actionable insights. By adhering to the highest clinical standards, we strive to enable personalized cancer treatment and improve patient outcomes through cutting-edge technology.

Product : 1